Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 7/2017

01-07-2017 | Editorial

Editors’ Introduction to the Chronic Pancreatitis and Pancreatic Cysts Special Issue

Authors: Walter G. Park, Aida Habtezion

Published in: Digestive Diseases and Sciences | Issue 7/2017

Login to get access

Excerpt

We are pleased to introduce the third annual special supplement to Digestive Diseases and Sciences dedicated to Emmet B. Keeffe, an endeavor not only intellectually but also personally satisfying since both of us have had the distinct privilege of working with Emmet as trainees at Stanford. …
Metadata
Title
Editors’ Introduction to the Chronic Pancreatitis and Pancreatic Cysts Special Issue
Authors
Walter G. Park
Aida Habtezion
Publication date
01-07-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4613-z

Other articles of this Issue 7/2017

Digestive Diseases and Sciences 7/2017 Go to the issue

Review

Pancreatic Cysts and Guidelines

Review

Chronic Pancreatitis: Current Status and Challenges for Prevention and Treatment

Review

Genetic Risk in Chronic Pancreatitis: The Trypsin-Dependent Pathway

Review

Complications of Chronic Pancreatitis

Review

Insights into the Pathogenesis of Pancreatic Cystic Neoplasms

Review

Endoscopic Management of Pancreatic Cysts
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits